FDA.reportPublic FDA data

3.2 ML aripiprazole 300 MG/ML Prefilled Syringe

RxCUI
2636645
RxNorm name
3.2 ML aripiprazole 300 MG/ML Prefilled Syringe
Display name
3.2 ML aripiprazole 300 MG/ML Prefilled Syringe
Full name
3.2 ML aripiprazole 300 MG/ML Prefilled Syringe
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
da4c07fd-1130-4341-bb44-63acfa4162be3.2 ML aripiprazole 300 MG/ML Prefilled SyringeSCD6These highlights do not include all the information needed to use ABILIFY ASIMTUFII safely and effectively. See full prescribing information for ABILIFY ASIMTUFII. ABILIFY ASIMTUFII ® (aripiprazole) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 200220250404
da4c07fd-1130-4341-bb44-63acfa4162bearipiprazole 960 MG per 3.2 ML extended release Prefilled SyringeSY6These highlights do not include all the information needed to use ABILIFY ASIMTUFII safely and effectively. See full prescribing information for ABILIFY ASIMTUFII. ABILIFY ASIMTUFII ® (aripiprazole) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 200220250404
da4c07fd-1130-4341-bb44-63acfa4162beARIPiprazole 960 MG in 3.2 ML Extended Release Prefilled SyringePSN6These highlights do not include all the information needed to use ABILIFY ASIMTUFII safely and effectively. See full prescribing information for ABILIFY ASIMTUFII. ABILIFY ASIMTUFII ® (aripiprazole) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 200220250404